Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · IEX Real-Time Price · USD

3.150

-0.010 (-0.32%)

At close: Apr 19, 2024, 4:00 PM

3.110

-0.040 (-1.27%)

After-hours: Apr 19, 2024, 7:40 PM EDT

Acumen Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	67.12	130.1	122.16	43.78	6.55
Short-Term Investments	176.64	47.5	72.08	0	0
Cash & Cash Equivalents	243.76	177.61	194.24	43.78	6.55
Cash Growth	37.25%	-8.56%	343.70%	568.15%	-
Receivables	0	0	0	0.11	0.03
Other Current Assets	2.86	2.72	4.42	0.54	0.6
Total Current Assets	246.62	180.33	198.66	44.43	7.18
Property, Plant & Equipment	0.5	0.27	0.04	0	0
Long-Term Investments	62.55	15.84	31.62	0	0
Other Long-Term Assets	0.45	0.15	0.01	0	0.14
Total Long-Term Assets	63.51	16.26	31.67	0	0.14
Total Assets	310.13	196.59	230.33	44.43	7.32
Accounts Payable	1.38	1.64	1.09	0.53	0.22
Current Debt	0.87	0.11	0	0	0
Other Current Liabilities	10.73	6.07	4.06	5.84	1.12
Total Current Liabilities	12.97	7.81	5.15	6.37	1.34
Long-Term Debt	30.18	0	0	0	0
Total Long-Term Liabilities	30.18	0	0	0	0
Total Liabilities	43.15	7.81	5.15	6.37	1.34
Total Debt	31.05	0.11	0	0	0
Debt Growth	29468.57%	-	-	-	-
Retained Earnings	-222.8	-170.43	-127.57	-26.97	-19.64
Comprehensive Income	0.31	-0.75	-0.23	0	0
Shareholders' Equity	266.97	188.78	225.18	-18.59	-11.42
Net Cash / Debt	212.71	177.5	194.24	43.78	6.55
Net Cash / Debt Growth	19.84%	-8.62%	343.70%	568.15%	-
Net Cash Per Share	4.38	4.37	9.68	104.45	15.21
Working Capital	233.64	172.52	193.51	38.06	5.84
Book Value Per Share	5.49	4.65	11.23	-44.36	-26.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).